Articles

P1.07 Unusual progression of a B-cell non-Hodgkin’s lymphoma

BJH - volume 6, issue Abstract Book BHS, january 2015

E. Collinge MD, A. vanden Daelen , L. Marot , A. Camboni MD, PhD, J-P. Defour PhD, P. Saussoy MD, PhD, L. Michaux MD, PhD, M-C. Vekemans MD, L. Knoops MD, PhD

Read more

P1.15 Outcome after salvage chemotherapy with DHAP/ICE-type regimens and attempt to transplant in patients with aggressive lymphoma: experience of a single centre

BJH - volume 6, issue Abstract Book BHS, january 2015

P.D.M. Katoto , N. Vanlangendonck , V. Havelange MD, PhD, X. Poiré MD, PhD, C. Lambert MD, M-C. Vekemans MD, A. Ferrant , V. Lannoy , E. Van den Neste MD, PhD

Read more

P3.15 Clofarabine as salvage therapy and bridge to transplantation in acute leukemia. A single center experience

BJH - volume 6, issue Abstract Book BHS, january 2015

G. Di Prinzio , C. Cornil , E. Collinge MD, A. Devresse , P.D.M. Katoto , V. Havelange MD, PhD, E. Van den Neste MD, PhD, X. Poiré MD, PhD, M-C. Vekemans MD

Read more

P4.06 A pernicious anemia hiding under the guise of a normocytic anemia

BJH - volume 6, issue Abstract Book BHS, january 2015

A. Dermine , J. Dewulf , J-P. Defour PhD, M-C. Vekemans MD

Read more

Update on the initial therapy of multiple myeloma

BJH - volume 5, issue 4, december 2014

M-C. Vekemans MD, K. Beel MD, PhD, J. Caers MD, PhD, N. Meuleman MD, PhD, G. Bries MD, PhD, V. Delrieu MD, H. Demuynck MD, B. De Prijck MD, H. De Samblanx MD, A. Deweweire MD, A. Kentos MD, PhD, P. Mineur MD, F. Offner MD, PhD, I. Vande Broek MD, PhD, A. Vande Velde MD, J. Van Droogenbroeck MD, KL. Wu MD, PhD, C. Doyen MD, PhD, R. Schots MD, PhD, M. Delforge MD, PhD

Summary

With the introduction of immunomodulatory drugs and proteasome inhibitors, major improvements have been achieved in the treatment and prognosis of multiple myeloma. Different treatment combinations are now in use and innovative therapies are being developed. This rapidly changing therapeutic landscape calls for an update on the Belgian myeloma guidelines, published in 2010.1 Based on an extensive review of the recent literature, the myeloma study group of the Belgian Hematology Society has revised the consensus recommendations on myeloma care, to be used by haematologists as a reference for daily practice. When applicable, comments with regards to the Belgian reimbursement modalities are included. The full text with appendices can be downloaded from the Belgian Hematology Society website (www.bhs.be) and from the Belgium Journal of Hematology website (www.ariez.com).

(BELG J HEMATOL 2014;5(4):125–36)

Read more

P3.08 Successful renal transplantation after autologous hematopoietic stem cell transplantation in anuric multiple myeloma

BJH - volume 5, issue Abstract Book BHS, january 2014

A. Dermine , J. Devreux , J.P. Cosyns , P. Saussoy MD, PhD, L. Labriola , M. Mourad , L. Michaux MD, PhD, X. Poiré MD, PhD, V. Havelange MD, PhD, M-C. Vekemans MD

Read more

P2.12 An unusual presentation of cryptococcal meningitis in a patient with lymphoplasmacytic dyscrasia

BJH - volume 5, issue Abstract Book BHS, january 2014

F. Van Obbergh MD, A. Ferrant , D. Wilmes , J. Yombi , L. Knoops MD, PhD, M-C. Vekemans MD, L. Michaux MD, PhD

Read more